We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TDG:NYSETransdigm Group Inc. Analysis

Data as of 2026-05-04 - not real-time

$1,152.64

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

TransDigm’s stock is trading at $1152.64, well below its 20‑day ($1201.24) and 50‑day ($1219.10) simple moving averages, with the 200‑day SMA ($1321.82) still far higher, signaling a bearish price environment. The 14‑day RSI of 41.7 and a bearish MACD histogram reinforce the downside momentum, while the price sits near the identified support level of $1128.21 and faces resistance around $1303.06. Fundamentally, the company posted 13.9% revenue growth and impressive operating (45.6%) and profit margins (22.2%), backed by robust operating cash flow of $2.12 B. However, the balance sheet is strained: total debt of $30.05 B dwarfs cash of $2.53 B, resulting in negative book value per share and a price‑to‑book ratio of –7.0. The forward PE of 25.2 is lower than the trailing PE of 37.1 but still above the industry average PE of 30.9, suggesting a premium valuation. Despite this, the discounted cash‑flow model indicates a 33% upside potential, implying the market may be undervaluing the stock relative to its intrinsic cash‑generating capacity. Recent news highlights an acquisition of Stellant Systems financed by $1.5 B of new debt and a de‑escalation of Middle‑East tensions that lifted commercial aviation demand, both of which could improve future earnings. Yet the same debt issuance caused a 3% share‑price dip, reflecting investor concern over leverage. Upcoming Q2 earnings on May 5 will be a key catalyst to confirm whether the growth narrative can offset the balance‑sheet risks. Overall, the stock sits at a crossroads between bearish technicals and potentially attractive valuation upside, with upcoming earnings and acquisition integration poised to tip the balance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish technical indicators (price below SMAs, RSI below 50, MACD negative)
  • Imminent earnings release adding uncertainty
  • Recent debt issuance raising leverage concerns

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong operating margins and cash flow generation
  • DCF‑derived upside of ~33% indicating undervaluation
  • Strategic acquisition of Stellant Systems expected to enhance earnings

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustained demand in aerospace & defense amid geopolitical trends
  • Consistent revenue growth and high profitability
  • Potential for debt reduction through cash flow over time

Key Metrics & Analysis

Financial Health

Revenue Growth13.90%
Profit Margin22.24%
P/E Ratio37.1
ROA11.78%
P/B Ratio-7.0
Op. Cash Flow$2.1B
Free Cash Flow$1.3B
Industry P/E30.9

Technical Analysis

TrendBearish
RSI41.7
Support$1,128.21
Resistance$1,303.06
MA 20$1,201.24
MA 50$1,219.10
MA 200$1,321.82
MACDBearish
VolumeIncreasing
Fear & Greed Index88.09

Valuation

Fair Value$72.47
Target Price$1,537.14
Upside/Downside33.36%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.79
Volatility34.88%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.